Walleye Capital
PRAX icon

Walleye Capital’s Praxis Precision Medicines PRAX Stock Holding History

Walleye Capital’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,587
Closed -$1.06M – 4846
2025
Q4 		$1.06M Buy
+3,587
New +$668K ﹤0.01% 2385
2025
Q2 		– Sell
-131,756
Closed -$4.99M – 4939
2025
Q1 		$4.99M Buy
131,756
+42,143
+47% +$2.63M 0.02% 786
2024
Q4 		$6.9M Buy
89,613
+34,000
+61% +$2.46M 0.02% 874
2024
Q3 		$3.2M Buy
+55,613
New +$3M 0.01% 1526
2023
Q1 		– Sell
-2,916
Closed -$104K – 4279
2022
Q4 		$104K Buy
2,916
+1,133
+64% +$35.3K ﹤0.01% 2345
2022
Q3 		$61K Buy
+1,783
New +$88.8K ﹤0.01% 2547

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Walleye Capital's PRAX Position: Q1 2026 in Review

Walleye Capital sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 3,587 shares — an estimated $1.06M sold.

Walleye Capital first reported a position in PRAX in Q3 2022 and held it in 6 quarters. The position peaked at $6.9M in Q4 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Walleye Capital reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 3,587 Praxis Precision Medicines shares in Q1 2026, an estimated $1.06M.
  • Walleye Capital first reported a position in Praxis Precision Medicines in Q3 2022 and held it in 6 quarters.
  • Walleye Capital's Praxis Precision Medicines position peaked at $6.9M in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.